Fair point, if you are just looking at the headline numbers.
The reality is 2H is a far more meaningful representation of the performance of the RXP business as it stands today.
2H NPAT of $4.3m, was a significant improvement of 1H NPAT of $2.2m. If you annualise 2H NPAT it significantly increases EPS metrics.
With July revenues in excess of $6m (FY14 average: $4.6m) and management forecasting "strong" earnings and revenue growth, the growth story remains very much intact.
RXP Price at posting:
75.0¢ Sentiment: Hold Disclosure: Held